BACKGROUND: Continuous femoral nerve blocks have been recommended for postoperative pain control after anterior cruciate ligament reconstruction. HYPOTHESIS: A pain control protocol involving a continuous ropivacaine femoral nerve block will decrease pain and narcotic use in the first 24 hours after surgery compared with a postoperative pain control protocol involving an intra-articular injection of bupivacaine/morphine. STUDY DESIGN: Randomized controlled clinical trial; Level of evidence, 2. METHODS:Ninety subjects, aged 15 years or older, who were receiving arthroscopically assisted bone-patellar tendon-bone anterior cruciate ligament reconstruction were randomly assigned to 2 groups. The first group received a ropivacaine continuous femoral nerve block and oral hydrocodone (block group). The second group received an intra-articular bupivacaine/morphine injection and oral oxycodone (injection group). Patients in both groups could receive intramuscular injection of hydromorphone for breakthrough pain; most patients in the block group also received bolus doses of ropivacaine through the femoral catheter. Subjects rated their worst, average, and current pain levels using a visual analog scale and category-ratio scale the morning after surgery. Postoperative narcotic pain medication use was converted to morphine-equivalent doses. RESULTS:Postoperative pain ratings did not differ between the treatment groups. The largest difference in pain ratings between the groups was 0.5 cm for worst pain level (P = .345). Total narcotic use did not differ significantly between groups (1.1 morphine-equivalent doses in both groups; P = .671). CONCLUSIONS: Continuous femoral block with ropivacaine appeared to have no clinical advantage in the immediate postoperative period after anterior cruciate ligament reconstruction when compared with an intra-articular injection of bupivacaine/morphine. Both methods are effective for pain control after anterior cruciate ligament reconstruction.
RCT Entities:
BACKGROUND: Continuous femoral nerve blocks have been recommended for postoperative pain control after anterior cruciate ligament reconstruction. HYPOTHESIS: A pain control protocol involving a continuous ropivacaine femoral nerve block will decrease pain and narcotic use in the first 24 hours after surgery compared with a postoperative pain control protocol involving an intra-articular injection of bupivacaine/morphine. STUDY DESIGN: Randomized controlled clinical trial; Level of evidence, 2. METHODS: Ninety subjects, aged 15 years or older, who were receiving arthroscopically assisted bone-patellar tendon-bone anterior cruciate ligament reconstruction were randomly assigned to 2 groups. The first group received a ropivacaine continuous femoral nerve block and oral hydrocodone (block group). The second group received an intra-articular bupivacaine/morphine injection and oral oxycodone (injection group). Patients in both groups could receive intramuscular injection of hydromorphone for breakthrough pain; most patients in the block group also received bolus doses of ropivacaine through the femoral catheter. Subjects rated their worst, average, and current pain levels using a visual analog scale and category-ratio scale the morning after surgery. Postoperative narcotic pain medication use was converted to morphine-equivalent doses. RESULTS:Postoperative pain ratings did not differ between the treatment groups. The largest difference in pain ratings between the groups was 0.5 cm for worst pain level (P = .345). Total narcotic use did not differ significantly between groups (1.1 morphine-equivalent doses in both groups; P = .671). CONCLUSIONS: Continuous femoral block with ropivacaine appeared to have no clinical advantage in the immediate postoperative period after anterior cruciate ligament reconstruction when compared with an intra-articular injection of bupivacaine/morphine. Both methods are effective for pain control after anterior cruciate ligament reconstruction.
Authors: Aaron J Krych; Sean Baran; Scott A Kuzma; Hugh M Smith; Rebecca L Johnson; Bruce A Levy Journal: Knee Surg Sports Traumatol Arthrosc Date: 2013-09-24 Impact factor: 4.342
Authors: Robert P Runner; Stephanie A Boden; William S Godfrey; Ajay Premkumar; Heather Samady; Michael B Gottschalk; John W Xerogeanes Journal: Orthop J Sports Med Date: 2018-09-26
Authors: Brendon C Mitchell; Matthew Y Siow; Andrew T Pennock; Eric W Edmonds; Tracey P Bastrom; Henry G Chambers Journal: Orthop J Sports Med Date: 2021-03-05
Authors: Ritwik Kejriwal; Jeremy Cooper; Andrew Legg; Jeremy Stanley; Michael P Rosenfeldt; Stewart J Walsh Journal: Orthop J Sports Med Date: 2018-10-10